Fmoc-D-beta-HPro-OH is an Fmoc-protected, β-hydroxyproline derivative in which the proline ring is substituted at the β-position and the α-amino group is masked with a 9H-fluoren-9-ylmethoxycarbonyl (Fmoc) protecting group, while the carboxyl group remains present as a free acid. The molecule contains the cyclic secondary amine within the proline scaffold, a β-hydroxy side-chain functional group capable of hydrogen bonding and derivatization, and stereochemistry is indicated by the "D" designation for the amino acid center. As a protected amino acid building block, it is used in stepwise peptide synthesis workflows such as solid-phase peptide synthesis to control chemoselectivity of the amino functionality and to introduce a β-hydroxyproline residue for peptide structure-property studies and chemical biology labeling strategies.
CAT No: CP25519
CAS No:193693-61-7
Synonyms/Alias:193693-61-7;(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)aceticacid;AmbotzFAA6610;Fmoc-D-?-Homopro-OH;CTK0H1495;MolPort-003-795-062;ZINC622107;CF-1187;AJ-23771;AK116141;KB-209696;ST24035242;2-Pyrrolidineaceticacid,1-[(9H-fluoren-9-ylmethoxy)carbonyl]-,(2R)-
Chemical Name:N-beta-(9-Fluorenylmethyloxycarbonyl)-D-homoproline, (R)-N-(9-Fluorenylmethyloxycarbonyl)-2-(pyrrolidin-2-yl)acetic acid
Fmoc-D-beta-HPro-OH is an Fmoc-protected, D-configured β-hydroxyproline amino acid derivative bearing a carboxylic acid for peptide coupling and a β-hydroxyl side-chain that can participate in hydrogen bonding and derivatization chemistry. The stereogenic center at the β-position (D-configuration) and the cyclic proline ring impose conformational constraints that influence amide bond formation, peptide secondary structure preferences, and downstream stereochemical outcomes. The Fmoc group on the α-amine functions as a base-labile protecting group compatible with standard solid-phase peptide synthesis workflows, while the free carboxyl group enables activation to form amide linkages. The β-hydroxyl functionality can be selectively protected, converted to leaving groups, or oxidized to carbonyl derivatives, making the compound a practical chiral intermediate for β-functionalized amino acid and peptide analog construction.
1. Peptide Synthesis
Fmoc-D-beta-HPro-OH is employed in peptide building block preparation for both solution-phase and solid-phase peptide synthesis, where the Fmoc-protected α-amine supports controlled N-deprotection and subsequent coupling. The β-hydroxyproline side chain provides an additional functional handle for hydrogen-bonding interactions and for generating β-hydroxyl-containing peptide motifs after deprotection. The carboxylic acid enables straightforward conversion to activated coupling species compatible with amide bond formation, supporting incorporation into peptide sequences that require a D-configured β-stereocenter. β-hydroxyproline-containing peptides can then be used to probe conformational effects, stability, and recognition features in peptide science and chemical biology workflows.
2. Amino Acid Modification
Fmoc-D-beta-HPro-OH is suitable for amino acid derivatization and side-chain functionalization strategies that exploit the β-hydroxyl group while retaining the chiral proline framework. The hydroxyl can be protected to enable orthogonal chemistry, converted to ether or ester derivatives to tune polarity, or transformed into carbonyl-containing analogs through oxidation chemistry for structure-function studies. The Fmoc group provides a protected amine that can be removed when peptide coupling or further elaboration requires exposure of the nucleophilic α-amine. Downstream derivatives prepared from this β-hydroxy amino acid intermediate can serve as chiral reagents for fine chemical synthesis, stereodefined scaffold generation, and targeted functional group installation on peptide-like backbones.
3. Peptidomimetics And SAR
Fmoc-D-beta-HPro-OH is applied in peptidomimetic construction and SAR studies where a constrained proline ring combined with a stereodefined β-hydroxyl can model specific backbone and side-chain interactions. The D-configuration at the β-position supports stereochemically controlled analog libraries that help evaluate how inversion of stereochemistry affects conformational bias, hydrogen bonding patterns, and binding-site complementarity. The Fmoc-protected α-amine and carboxylic acid allow incorporation into analog series through peptide coupling chemistry, enabling systematic variation of neighboring residues while keeping the β-functional motif constant. Peptidomimetic scaffolds derived from this chiral amino acid intermediate can be used to generate structure-defined libraries for mechanistic investigations and molecular design iteration.
4. Chemical Biology Labeling
Fmoc-D-beta-HPro-OH supports chemical biology research and biomolecule labeling workflows that require stereochemically defined β-hydroxyproline residues for recognition and conjugation studies. The β-hydroxyl functionality can be leveraged for conjugation chemistry after conversion to activated intermediates or after orthogonal protection/deprotection to control chemoselectivity. The Fmoc group enables assembly of labeled peptides or peptide conjugates under conditions that preserve the D-β stereocenter until late-stage functionalization. Resulting β-hydroxyproline-containing probes can be incorporated into peptide conjugates used for studying molecular recognition, interaction mapping, and biomolecular assembly processes.
5. Pharmaceutical Intermediate Preparation
Fmoc-D-beta-HPro-OH is relevant to pharmaceutical intermediate preparation and process chemistry intermediate design due to its protected amino acid format and robust functional group set for controlled downstream transformations. The Fmoc-protected α-amine and free carboxylic acid allow manufacturing routes that sequence N-deprotection, activation, and coupling steps while maintaining stereochemical integrity of the D-β center. The β-hydroxyl group can be managed through protection strategies to enable orthogonal chemistry during synthesis of peptide-like intermediates and constrained amino acid derivatives used in medicinal chemistry campaigns. Industrially, this compound can serve as a chiral building block for producing stereodefined peptide analogs and functionalized amino acid fragments that feed into broader fine chemical and specialty chemical production pipelines.
2. The spatiotemporal control of signalling and trafficking of the GLP-1R
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.